Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.

By B. Rogers, H. Sidjabat, David L. Paterson. Journal of Antimicrobial Chemotherapy, 2011

759 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. (2011, background): “The current geographic distribution of ST131 and its resistance traits have been reviewed recently (Rogers et al., 2011).”
CTX-M Enzymes: Origin and Diffusion (2012, background): “…and Chemotherapy April 2012 | Volume 3 | Article 110 | 2 blaCTX-M genes in highly mobilizable genetic platforms, including plasmids and transposons, but also because of these platforms within successful clones (Cantón and Coque, 2006; Rogers et al., 2011; Woodford et al., 2011; Figure 2).”
Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. (2012, positive): “ST131 ancestrally derived from EcoR B2, which contains highly virulent ExPEC, and its combination of multiresistance and virulence is discussed as likely reason for the pandemic success of this ST [2,37,41].”